IGFL2 and renal cell carcinoma: Some most recent researches showed RAC2, LINC00160, IGFL2-AS1, AC023043.1 could serve as biomarkers for diagnosing RCC (Cheng et al., 2019; Liu et al., 2019; Cheng et al., 2020).